328
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Plasmonic Photothermal Therapy of Atherosclerosis With Nanoparticles: long-term Outcomes and Safety in NANOM-FIM Trial

, , , , &
Pages 345-363 | Received 14 Feb 2017, Accepted 24 May 2017, Published online: 23 Jun 2017

References

  • Petrukhin I , LuninaEY . Cardiovascular disease risk factors and mortality in Russia: challenges and barriers . Pub. Health Rev.33 ( 2 ), 436 – 449 ( 2012 ).
  • Muramatsu T , OnumaY, ZhangYJet al. Progress in treatment by percutaneous coronary intervention: the stent of the future . Rev. Esp. Cardiol.66 ( 6 ), 483 – 496 ( 2013 ).
  • Onuma Y , MuramatsuT, KharlamovA, SerruysPW . Freeling the vessel from metallic cage: what can we achieve with bioresorbable vascular scaffolds?Cardiovasc. Interv. Ther.27 ( 3 ), 141 – 154 ( 2012 ).
  • Kharlamov A , GabinskyJ . Plasmonic nanophotothermal and stem cell therapy of atherosclerotic plaque as the novel tool for angioplasty and artery remodeling . Rejuvenation Res.15 ( 2 ), 222 – 230 ( 2012 ).
  • Godin B , SakamotoJH, SerdaRE, GrattoniA, BouamraniA, FerrariM . Emerging applications of nanomedicine for therapy and diagnosis of cardiovascular diseases . Trends Pharmacol. Sci.31 ( 5 ), 199 – 205 ( 2010 ).
  • Jayagopal A , LintonMF, FazioS, HaseltonFR . Insights into atherosclerosis using nanotechnology . Curr. Arterioscler. Rep.12 ( 3 ), 209 – 215 ( 2010 ).
  • Tang J , LobattoME, ReadJC, MieszawskaAJ, FayadZA, MulderWJ . Nanomedical theranostics in cardiovascular disease . Curr. Cardiovasc. Imaging Rep.5 ( 1 ), 19 – 25 ( 2012 ).
  • Wang B , EmelianovS . Thermal intravascular photoacoustic imaging . Biomedical Optics Express.2 ( 11 ), 3072 – 3078 ( 2011 ).
  • Kharlamov AN , TyurninaAE, VeselovaVS, KovtunOP, ShurVY, GabinskyJL . Silica-gold nanoparticles for atheroprotective management of plaques: results of the NANOM-FIM trial . Nanoscale7 ( 17 ), 8003 – 8015 ( 2015 ).
  • Kharlamov AN . Plasmonic photothermal therapy for atheroregression below Glagov threshold . Future Cardiol.9 ( 3 ), 405 – 425 ( 2013 ).
  • Yeager D , ChenYS, LitovskyS, EmelianovS . Intravascular photoacoustics for image-guidance and temperature monitoring during plasmonic photothermal therapy of atherosclerotic plaques: a feasibility study . Theranostics4 ( 1 ), 36 – 46 ( 2013 ).
  • Nicholls SJ , BallantyneCM, BarterPJet al. Effect of two intensive statin regimens on progression of coronary disease . N. Engl. J. Med.365 ( 22 ), 2078 – 2087 ( 2011 ).
  • Nissen S , TsunodaT, TuzcuEMet al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial . J. Am. Med. Assoc.290 ( 17 ), 2292 – 2300 ( 2003 ).
  • Oberdorster G . Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology . J. Intern. Med.267 ( 1 ), 89 – 105 ( 2009 ).
  • Van Hoecke K , De SchamphelaereKA, AliZet al. Ecotoxicity and uptake of polymer coated gold nanoparticles . Nanotoxicology7 ( 1 ), 37 – 47 ( 2013 ).
  • Lee KY , LeeYW, KwonK . One-step fabrication of gold nanoparticles-silica composites with enhanced catalytic activity . Chem. Physics Lett.453 ( 1–3 ), 77 – 81 ( 2008 ).
  • Glagov S , WeisenbergE, ZarinsCK . Compensatory enlargement of human atherosclerotic coronary arteries . N. Engl. J. Med.316 ( 22 ), 1371 – 1375 ( 1987 ).
  • Stuckler D , KingL, McKeeM . Mass privatization and the post-communist mortality crisis: a cross-national analysis . Lancet373 ( 9661 ), 399 – 407 ( 2009 ).
  • Kozlova E , ChernyshA, MorozVet al. Transformation of membrane nanosurface of red blood cells under hemin action . Sci. Rep.4, 6033 ( 2014 ).
  • Lapotko D . Plasmonic nanoparticle-generated photothermal bubbles and their biomedical applications . Nanomedicine (Lond.)4 ( 7 ), 813 – 845 ( 2009 ).
  • Cai W , GaoT, HongH . Applications of gold nanoparticles in cancer nanotechnology . Nanotechnol. Sci. Appl. 2008 ( 1 ), 17 – 32 ( 2008 ).
  • Chen PC , MwakwariSC, OyelereAK . Gold nanoparticles: from nanomedicine to nanosensing . Nanotechnol. Sci. Appl. 2008 ( 1 ), 45 – 66 ( 2008 ).
  • Katsnelson BA , PrivalovaLI, GurvichVBet al. Comparative in vivo assessment of some adverse bioeffects of equidimensional gold and silver nanoparticles and the attenuation of nanosilver’s effects with a complex of innocuous bioprotectors . Int. J. Mol. Sci.14 ( 2 ), 2449 – 2483 ( 2013 ).
  • Lobatto ME , FusterV, FayadZA, MulderWJ . Perspectives and opportunities for nanomedicine in the management of atherosclerosis . Nat. Rev. Drug Discov.10 ( 11 ), 835 – 852 ( 2011 ).
  • Maksimova IL , AkchurinGG, KhlebtsovBN . Near-infrared laser photothermal therapy of cancer by using gold nanoparticles: computer simulations and experiment . Med. Laser Appl.22 ( 3 ), 199 – 206 ( 2007 ).
  • Pan Y , NeussS, LeifertAet al. Size-dependent cytotoxicity of gold nanoparticles . Small3 ( 11 ), 1941 – 1949 ( 2007 ).
  • Alkilani AM , MurphyCJ . Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?J. Nanopart. Res.12 ( 7 ), 2313 – 2333 ( 2010 ).
  • Singh N , JenkinsGJS, AsadiR, DoakSH . Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION) . Nano Rev.1, 1 – 15 ( 2010 ).
  • Nissen SE , NichollsSJ, SipahiIet al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial . J. Am. Med. Assoc.295 ( 13 ), 1556 – 1565 ( 2006 ).
  • Wender H , AndreazzaML, CorreiaRR, TeixeiraSR, DupontJ . Synthesis of gold nanoparticles by laser ablation of an Au foil inside and outside ionic liquids . Nanoscale3 ( 3 ), 1240 ( 2011 ).
  • Lin J , ZhangH, ChenZ, ZhengY . Penetration of lipid membranes by gold nanoparticles: insights into cellular uptake, cytotoxicity, and their relationship . ACS Nano4 ( 9 ), 5421 – 5429 ( 2010 ).
  • Tyurnina AE , ShurVY, KozinRV, KuznetsovDK, MingalievEA . Synthesis of stable silver colloids by laser ablation in water . Proc. SPIE9065, D90650 ( 2013 ).
  • Oldenburg SJ , JacksonJB, WestcottSL, HalasNJ . Infrared extinction properties of gold nanoshells . Appl. Phys. Lett.75 ( 19 ), 2897 – 2899 ( 2016 ).
  • Hirsch LR , StaffordRJ, BanksonJAet al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance . Proc. Natl Acad. Sci. USA100 ( 23 ), 13549 – 13554 ( 2003 ).
  • Cormode DP , RoesslE, ThranAet al. Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles . Radiology256 ( 3 ), 774 – 782 ( 2010 ).
  • Rockson SG , KramerP, RazaviMet al. Photoangioplasty for human peripheral atherosclerosis: results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin) . Circulation102 ( 19 ), 2322 – 2324 ( 2000 ).
  • Tucker – Schwartz JM , HongT, ColvinDC, XuY, SkalaMC . Dual modality photothermal optical coherence tomography and magnetic resonance imaging of carbon nanotubes . Opt. Lett.37 ( 5 ), 872 – 874 ( 2012 ).
  • Wang X , WangC, ChengL, LeeST, LiuZ . Noble metal coated single-walled carbon nanotubes for applications in surface enhanced Raman scattering imaging and photothermal therapy . J. Am. Chem. Soc.134 ( 17 ), 7414 – 7422 ( 2012 ).
  • Son D , LeeJ, LeeDJet al. Bioresorbable electronic stent integrated with therapeutic nanoparticles for endovascular diseases . ACS Nano9 ( 6 ), 5937 – 5946 ( 2015 ).
  • Kharlamov AN . Why do we fail to achieve Glagovian atheroregression in lipid-lowering trials?Intervent. Cardiol.7 ( 5 ), 469 – 482 ; 10.2217ica.15.37 ( 2015 ).
  • Thygesen K , AlpertJS, WhiteHD . Universal definition of myocardial infarction . Eur. Heart J.28 ( 20 ), 2525 – 2538 ( 2007 ).
  • Thygesen K , AlpertJS, JaffeASet al. Third universal definition of myocardial infarction . Eur. Heart J.33 ( 20 ), 2551 – 2567 ( 2012 ).
  • Adams HP , AdamsRJ, BrottTet al. Guidelines for the early management of patients with ischemic stroke . Stroke34, 1056 – 1083 ( 2003 ).
  • Kharlamov AN . Cardiovascular burden and percutaneous interventions in Russian Federation: systematic epidemiological update . Cardiovasc Diagn Ther.7 ( 1 ), 60 – 84 ( 2017 ).
  • Kharlamov AN . Glimpse into the future of nanotheranostic strategies for regression of atherosclerosis through the prism of systems biomedicine: systematic review of innovations from multifunctional nanoformulations to devices on chip . Curr. Nanomedicine6 ( 3 ), 186 – 218 ( 2016 ).
  • Carlander U , LiD, JollietO, EmondC, JohansonG . Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles . Int. J. Nanomedicine 2016 ( 11 ), 625 – 640 ( 2016 ).
  • Rothen-Rutishauser BM , SchürchS, HaenniB, KappN, GehrP . Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques . Environ. Sci. Technol.40 ( 14 ), 4353 – 4359 ( 2006 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.